Related Experiment Video
Updated: Nov 20, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery
Seyedeh Roya Alizadeh1, Seyedeh Mahdieh Hashemi2
1Student Research Committee, Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:
Currently, the development of anticancer drug resistance is significantly restricted the clinical efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely prevalent and considered to be the major challenges of this century, which concerns the medical community all over the world. Consequently, investigating small molecule antitumor agents, which could decrease drug resistance and reduce unpleasant side effect is more desirable. 2-aminothiazole scaffold has emerged as a promising scaffold in medicinal chemistry and drug discovery research. This nucleus is a fundamental part of some clinically applied anticancer drugs such as dasatinib and alpelisib. Literature survey documented that different 2-aminothiazole analogs exhibited their potent and selective nanomolar inhibitory activity against a wide range of human cancerous cell lines such as breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, and prostate. In this paper, we have reviewed the progresses and structural modification of 2-aminothiazole to pursuit potent anticancers and also highlighted in vitro activities and in silico studies. The information will useful for future innovation. Representatives of 2-aminothiazole-containing compounds classification.
Insights
Researchers explored 2-aminothiazole compounds as novel anticancer agents to overcome drug resistance. These small molecules show potent activity against various cancer cell lines, offering potential for new cancer therapies.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Oncology
Background:
- Anticancer drug resistance limits the effectiveness of current treatments for prevalent malignant diseases.
- There is a critical need for novel small molecule antitumor agents with reduced side effects and improved efficacy.
- The 2-aminothiazole scaffold is a recognized privileged structure in medicinal chemistry, present in approved anticancer drugs.
Purpose of the Study:
- To review recent advancements in the structural modification of 2-aminothiazole derivatives for enhanced anticancer activity.
- To summarize the in vitro biological activities of 2-aminothiazole analogs against diverse human cancer cell lines.
- To highlight the role of in silico studies in the design and development of novel 2-aminothiazole-based anticancer agents.
Main Methods:
- Comprehensive literature survey on 2-aminothiazole derivatives and their anticancer properties.
- Analysis of structure-activity relationships (SAR) for various 2-aminothiazole analogs.
- Review of in vitro experimental data and in silico computational studies.
Main Results:
- Numerous 2-aminothiazole analogs demonstrate potent and selective nanomolar inhibitory activity against a broad spectrum of cancer cell lines (breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, prostate).
- Structural modifications of the 2-aminothiazole core have led to compounds with significant antitumor potential.
- In vitro and in silico investigations support the therapeutic promise of this chemical class.
Conclusions:
- The 2-aminothiazole scaffold is a valuable platform for developing next-generation anticancer drugs.
- Continued research into structural modifications and biological evaluation of 2-aminothiazole derivatives is warranted.
- This review provides a foundation for future innovation in the design of effective anticancer agents targeting drug resistance.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Physical Properties of Amines
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs that Destabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

